Skip to content

Telerehabilitation in Hemato-oncological Survivors

Remotely Monitored Rehabilitation in Hemato-oncological Survivors After Treatment: The Tele@Home Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05779605
Acronym
Tele@home
Enrollment
80
Registered
2023-03-22
Start date
2023-04-01
Completion date
2026-12-31
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic Malignancy, Lymphoma

Brief summary

This study investigates whether the 12-week home-based exercise training with remote guidance and telemonitoring compared to regular center-based training leads to better long-term cardiorespiratory fitness and physical activity levels in post-treatment patients with lymphoma.

Detailed description

80 lymphoma cancer patients post-treatment (except adjuvant treatment) will be enrolled in the study. Cardiorespiratory fitness (peak oxygen consumption), adverse events, body composition, quality of life, costs and adherence to exercise prescription will be evaluated at baseline, 12-week, and year after enrollment. Investigators assume that home-based training with remote guidance and telemonitoring with objective training data obtained during rehabilitation after cancer treatment will improve long-term motivation and effectiveness of independent training in cancer survivors, resulting in superior cardiorespiratory fitness and physical activity levels.

Interventions

Patients will be instructed to perform three weekly training sessions at home (30 to 50 min/session, at an intensity of 70-85% of their maximum heart rate). Patients in the home training group complete the first three training sessions in the clinic under direct supervision. During these sessions, patients are introduced to the duration and intensity of training. The trainer will provide remote guidance (feedback on training frequency, duration, and intensity) via telephone call once a week. During exercise, patients will use a wearable heart rate monitor (Polar M430, a commercially available device designed for long-term use). Patients will be instructed to properly use the wearable sensor and upload training data to a web-based platform (Polar Flow) via the Internet. Furthermore, patients will be asked to choose their preferred training modality at home (cycling, walking, Nordic walking) and receive instructions and advice.

DEVICECenter-based training

Patients receive three training sessions a week with 30 to 50 min duration at 70 - 90% of their maximal heart rate at the outpatient clinic under direct supervision. Exercise modalities will be walking on a treadmill, riding a bicycle ergometer, and resistance training. Physiotherapists will track the attendance rate and training adherence during the training program.

Sponsors

Brno University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Participants * with hemato-oncological malignancy / lymphoma (in last two months) * after cancer systemic chemotherapy-based treatment * with clinically stable state * with the ability to perform a cardiopulmonary exercise test * with the ability to understand and write in the Czech language * with an internet connection at home * literacy with information and communication technology

Exclusion criteria

Participants * with acute heart disease or decompensation in the previous six weeks, * with psychological severe, cognitive disorders, * serious training limitations (musculoskeletal disorders) * currently carried out the recommendations for physical activity (150min per week) * who take part in a training program under supervision elsewhere

Design outcomes

Primary

MeasureTime frameDescription
Cardiorespiratory fitnessChange from baseline to 12 weeks and 52 weeksPeak oxygen uptake during cardiopulmonary exercise test

Secondary

MeasureTime frameDescription
Satisfaction - self-completed questionnaire12 weeks and 52 weeksSubjects will be provided with a 5-item self-completed questionnaire developed by our research team that will measure their satisfaction with the intervention they received and the study in general. The items will be presented in the form of statements to which subjects will be asked to respond using a 1-5 Likert scale (strongly agree, agree, not sure, disagree, and strongly disagree).
Body waterChange from baseline to 12 weeks and 52 weeksTotal body water in liters will be measured by bioelectrical impedance analysis.
Muscle massChange from baseline to 12 weeks and 52 weeksTotal muscle mass in kilograms will be measured by bioelectrical impedance analysis.
Health-related quality of lifeChange from baseline to 12 weeks and 52 weeksHealth-related quality of life (SF-36 Form) yields a score for each domain of health. All domains are scored on a scale from 0 (negative health) to 100 (positive health), with 100 representing the best possible health state
Incidence of exercise adverse events assessed by 5 grade scaleData will be recorded continuously from the intervention's baseline for 12 weeks and then for 52 weeksParticipants will be encouraged to use the contact details for reporting incidence of exercise adverse events at any time throughout the study period. The type, incidence, and severity of adverse events by scale (Grade 1: Mild, asymptomatic or mild symptoms; Grade 2: Moderate, minimal; Grade 3: Severe or medically significant; Grade 4: Life-threatening consequences; and Grade 5: Death) will be noted.
Training adherence (Number of compliant participants)12 weeksEvaluation of the total number of compliant participants (The criterium of compliance with the rehabilitation program is set at 70% of the prescribed training lessons, 100% = 36 lessons)
Maximum Grip StrengthChange from baseline to 12 weeks and 52 weeksMaximum grip strength during dynamometer evaluation
Body fat percentageChange from baseline to 12 weeks and 52 weeksBody fat percentage will be measured by bioelectrical impedance analysis.

Countries

Czechia

Contacts

Primary ContactKaterina Filakova
filakova.katerina@fnbrno.cz00420532233123

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026